Select Medical Holdings Corp 2024年度报告

TABLE OF CONTENTS INDEX TO FINANCIAL STATEMENTS Table of Contents UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Form10-K ☒ANNUAL REPORT PURSUANT TO SECTION13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 For fiscal year endedDecember31, 2024 OR☐TRANSITION REPORT PURSUANT TO SECTION13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 For the transition period fromtoCommission file numbers:001-34465 SELECT MEDICAL HOLDINGS CORPORATION(Exact name of Registrant as specified in its Charter) 4714 Gettysburg Road,P.O.Box2034Mechanicsburg,PA,17055(Address of Principal Executive Offices and Zip Code)(717)972-1100(Registrant’s telephone number, including area code) Securities registered pursuant to Section12(b) of the Act: Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule405 of the Securities Act.Yes☒No☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section13 or Section15(d) of the Act.Yes☐No☒ Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d) of the Securities Exchange Act of 1934 during the precedingtwelve months (or for such shorter period that the registrant was required to file such reports), and (2)has been subject to such filing requirements for the past 90days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 of RegulationS-T (§232.405of this chapter) during the preceding twelve months (or for such shorter period that the registrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule12b-2 of the Exchange Act. (Check one): Accelerated filer☐Non-accelerated filer☐Smaller reporting company☐Emerging growth company Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reportingunder Section 404(b) of the Sarbanes-Oxley Act by the registered public accounting firm that prepared or issued its audit report.☒ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correctionof an error to previously held financial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’sexecutive officers during the relevant recovery period pursuant to Section 240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the Act).Yes☐No☒ The aggregate market value of the registrant’s voting stock held by non-affiliates at June30, 2024 (the last business day of the registrant’s most recently completed second fiscalquarter) was approximately $3,622,619,762, based on the closing price per share of common stock on that date of $35.06 as reported on the New York Stock Exchange. Shares of common stockknown by the registrant to be beneficially owned by directors and officers of the registrant subject to the reporting and other requirements of Section16 of the Securities Exchange Act of 1934are not included in the computation. The registrant, however, has made no determination that such persons are “affiliates” within the meaning of Rule12b-2 under the Securities Exchange Actof 1934. As of February 1, 2025, the number of shares of Holdings’ Common Stock, $0.001 par value, outstanding was128,962,850. Unless the context indicates otherwise, any reference in this report to “Holdings” refers to Select Medical Holdings Corporation and any reference to “Select” refers to SelectMedical Corporation, the wholly owned operating subsidiary of Holdings, and any of Select’s subsidiaries. Any reference to “Concentra” refers to Concentra Group Holdings Parent,LLC(“Concentra Group Holdings Parent”) and its subsidiaries, including Concentra Inc. References to the “Company,” “we,” “us,” and “our” refer collectively to Holdings, Select, and Concentra. Documents Incorporated by Reference Listed hereunder are the documents, any portions of which are incorporated by reference and the Parts of this Form10-K into which such portions are incorporated: 1.The registrant's definitive proxy statement for use in connection with the 2025 Annual Meeting of Stockholders to be held on or about April 30, 2025 to be filed within 120days after theregistrant’s fiscal year ended December31, 2024, portions of which are incorporated by reference into PartIII of this Form